Polypharmacology–foe or friend?
JU Peters - Journal of medicinal chemistry, 2013 - ACS Publications
Polypharmacology describes the activity of compounds at multiple targets. Current research
focuses on two aspects of polypharmacology:(1) unintended polypharmacology can lead to …
focuses on two aspects of polypharmacology:(1) unintended polypharmacology can lead to …
[HTML][HTML] Towards Improved Human In Vitro Models for Cardiac Arrhythmia: Disease Mechanisms, Treatment, and Models of Atrial Fibrillation
C Cofiño-Fabres, R Passier, V Schwach - Biomedicines, 2023 - mdpi.com
Heart rhythm disorders, arrhythmias, place a huge economic burden on society and have a
large impact on the quality of life of a vast number of people. Arrhythmias can have genetic …
large impact on the quality of life of a vast number of people. Arrhythmias can have genetic …
Atrial‐like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial‐selective pharmacology
HD Devalla, V Schwach, JW Ford, JT Milnes… - EMBO molecular …, 2015 - embopress.org
Drugs targeting atrial‐specific ion channels, Kv1. 5 or Kir3. 1/3.4, are being developed as
new therapeutic strategies for atrial fibrillation. However, current preclinical studies carried …
new therapeutic strategies for atrial fibrillation. However, current preclinical studies carried …
Discovery and Biomimetic Semisynthesis of Spirophyllines A–D from Uncaria rhynchophylla
HF Zhou, WY Li, Q Wu, J Ren, LY Peng, XN Li… - Organic …, 2023 - ACS Publications
Spirophyllines A–D (1–4), four new spirooxindole alkaloids all characterized by the spiro
[pyrrolidin-3, 3′-oxindole] core and a rare isoxazolidine ring, were isolated from Uncaria …
[pyrrolidin-3, 3′-oxindole] core and a rare isoxazolidine ring, were isolated from Uncaria …
[HTML][HTML] Patch-clamp recordings of action potentials from human atrial myocytes: optimization through dynamic clamp
AO Verkerk, GA Marchal, JG Zegers… - Frontiers in …, 2021 - frontiersin.org
Introduction: Atrial fibrillation (AF) is the most common cardiac arrhythmia. Consequently,
novel therapies are being developed. Ultimately, the impact of compounds on the action …
novel therapies are being developed. Ultimately, the impact of compounds on the action …
Effect of selective IK,ACh inhibition by XAF‐1407 in an equine model of tachypacing‐induced persistent atrial fibrillation
MF Fenner, H Carstensen… - British journal of …, 2020 - Wiley Online Library
Background and Purpose Inhibition of the G‐protein gated ACh‐activated inward rectifier
potassium current, IK, ACh may be an effective atrial selective treatment strategy for atrial …
potassium current, IK, ACh may be an effective atrial selective treatment strategy for atrial …
New directions in antiarrhythmic drug therapy for atrial fibrillation
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia and has a significant impact on
morbidity and mortality. Current antiarrhythmic drugs for AF suffer from limited safety and …
morbidity and mortality. Current antiarrhythmic drugs for AF suffer from limited safety and …
[HTML][HTML] The relevance of GIRK channels in heart function
A Campos-Ríos, L Rueda-Ruzafa, JA Lamas - Membranes, 2022 - mdpi.com
Among the large number of potassium-channel families implicated in the control of neuronal
excitability, G-protein-gated inwardly rectifying potassium channels (GIRK/Kir3) have been …
excitability, G-protein-gated inwardly rectifying potassium channels (GIRK/Kir3) have been …
Constitutive activity of the acetylcholine-activated potassium current IK, ACh in cardiomyocytes
Stimulation of the vagal nerve slows the heart rate and leads to shorter action potential
duration in the atria. These effects are mainly mediated by binding of the vagal …
duration in the atria. These effects are mainly mediated by binding of the vagal …
Atrial-selective potassium channel blockers
Atrial fibrillation (AF), the most frequent cardiac arrhythmia, is associated with increased
morbidity and mortality. 1 Currently available pharmacologic interventions for AF have major …
morbidity and mortality. 1 Currently available pharmacologic interventions for AF have major …